Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
about
CYP2B6*6 is associated with increased breast cancer risk.The UGT1A6_19_GG genotype is a breast cancer risk factor.Polymorphism of CYP1A1 gene and susceptibility to childhood acute lymphoblastic leukemia in Egypt.Functional polymorphisms of xenobiotics metabolizing enzymes-a research topic.Gene variants of CYP1A1 and CYP2D6 and the risk of childhood acute lymphoblastic leukaemia; outcome of a case control study from Kashmir, India.
P2860
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@ast
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@en
type
label
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@ast
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@en
prefLabel
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@ast
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@en
P2860
P356
P1476
Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.
@en
P2093
Christina Justenhoven
P2860
P356
10.3389/FGENE.2012.00258
P577
2012-11-28T00:00:00Z